Table of Contents
1 CAR T-Cell Therapy for Multiple Myeloma Market Overview
1.1 Product Overview and Scope of CAR T-Cell Therapy for Multiple Myeloma
1.2 Classification of CAR T-Cell Therapy for Multiple Myeloma by Types
1.2.1 Global CAR T-Cell Therapy for Multiple Myeloma Revenue Comparison by Types (2017-2023)
1.2.2 Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Types in 2017
1.2.3 Monotherapy
1.2.4 Combination Therapy
1.3 Global CAR T-Cell Therapy for Multiple Myeloma Market by Application
1.3.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Multiple Myeloma
1.3.3 Refractory or Relapsed Multiple Myeloma
1.4 Global CAR T-Cell Therapy for Multiple Myeloma Market by Regions
1.4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) CAR T-Cell Therapy for Multiple Myeloma Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) CAR T-Cell Therapy for Multiple Myeloma Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CAR T-Cell Therapy for Multiple Myeloma Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) CAR T-Cell Therapy for Multiple Myeloma Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CAR T-Cell Therapy for Multiple Myeloma Status and Prospect (2013-2023)
1.5 Global Market Size of CAR T-Cell Therapy for Multiple Myeloma (2013-2023)
2 Manufacturers Profiles
2.1 Juno Therapeutics
2.1.1 Business Overview
2.1.2 CAR T-Cell Therapy for Multiple Myeloma Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Juno Therapeutics CAR T-Cell Therapy for Multiple Myeloma Revenue, Gross Margin and Market Share (2016-2017)
2.2 Kite Pharma
2.2.1 Business Overview
2.2.2 CAR T-Cell Therapy for Multiple Myeloma Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Kite Pharma CAR T-Cell Therapy for Multiple Myeloma Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 CAR T-Cell Therapy for Multiple Myeloma Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis CAR T-Cell Therapy for Multiple Myeloma Revenue, Gross Margin and Market Share (2016-2017)
2.4 Collectis
2.4.1 Business Overview
2.4.2 CAR T-Cell Therapy for Multiple Myeloma Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Collectis CAR T-Cell Therapy for Multiple Myeloma Revenue, Gross Margin and Market Share (2016-2017)
3 Global CAR T-Cell Therapy for Multiple Myeloma Market Competition, by Players
3.1 Global CAR T-Cell Therapy for Multiple Myeloma Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 CAR T-Cell Therapy for Multiple Myeloma Players Market Share
3.2.2 Top 10 CAR T-Cell Therapy for Multiple Myeloma Players Market Share
3.3 Market Competition Trend
4 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions
4.1 Global CAR T-Cell Therapy for Multiple Myeloma Revenue and Market Share by Regions
4.2 North America CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
4.3 Europe CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
4.5 South America CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
5 North America CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries
5.1 North America CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries (2013-2018)
5.2 USA CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
5.3 Canada CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
5.4 Mexico CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
6 Europe CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries
6.1 Europe CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries (2013-2018)
6.2 Germany CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
6.3 UK CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
6.4 France CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
6.5 Russia CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
6.6 Italy CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
7 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries
7.1 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries (2013-2018)
7.2 China CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
7.3 Japan CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
7.4 Korea CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
7.5 India CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
8 South America CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries
8.1 South America CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries (2013-2018)
8.2 Brazil CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
8.3 Argentina CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
8.4 Colombia CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue CAR T-Cell Therapy for Multiple Myeloma by Countries
9.1 Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries (2013-2018)
9.2 Saudi Arabia CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
9.3 UAE CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
9.4 Egypt CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
9.5 Nigeria CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
9.6 South Africa CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
10 Global CAR T-Cell Therapy for Multiple Myeloma Market Segment by Type
10.1 Global CAR T-Cell Therapy for Multiple Myeloma Revenue and Market Share by Type (2013-2018)
10.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Forecast by Type (2018-2023)
10.3 Monotherapy Revenue Growth Rate (2013-2023)
10.4 Combination Therapy Revenue Growth Rate (2013-2023)
11 Global CAR T-Cell Therapy for Multiple Myeloma Market Segment by Application
11.1 Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Application (2013-2018)
11.2 CAR T-Cell Therapy for Multiple Myeloma Market Forecast by Application (2018-2023)
11.3 Multiple Myeloma Revenue Growth (2013-2018)
11.4 Refractory or Relapsed Multiple Myeloma Revenue Growth (2013-2018)
12 Global CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2018-2023)
12.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2018-2023)
12.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Forecast by Regions (2018-2023)
12.3 North America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
12.4 Europe CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
12.6 South America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and FiguresFigure CAR T-Cell Therapy for Multiple Myeloma Picture
Table Product Specifications of CAR T-Cell Therapy for Multiple Myeloma
Table Global CAR T-Cell Therapy for Multiple Myeloma and Revenue (Million USD) Market Split by Product Type
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Types in 2017
Figure Monotherapy Picture
Figure Combination Therapy Picture
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) by Application (2013-2023)
Figure CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Applications in 2017
Figure Multiple Myeloma Picture
Figure Refractory or Relapsed Multiple Myeloma Picture
Table Global Market CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2013-2023)
Table Juno Therapeutics Basic Information, Manufacturing Base and Competitors
Table Juno Therapeutics CAR T-Cell Therapy for Multiple Myeloma Type and Applications
Table Juno Therapeutics CAR T-Cell Therapy for Multiple Myeloma Revenue, Gross Margin and Market Share (2016-2017)
Table Kite Pharma Basic Information, Manufacturing Base and Competitors
Table Kite Pharma CAR T-Cell Therapy for Multiple Myeloma Type and Applications
Table Kite Pharma CAR T-Cell Therapy for Multiple Myeloma Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis CAR T-Cell Therapy for Multiple Myeloma Type and Applications
Table Novartis CAR T-Cell Therapy for Multiple Myeloma Revenue, Gross Margin and Market Share (2016-2017)
Table Collectis Basic Information, Manufacturing Base and Competitors
Table Collectis CAR T-Cell Therapy for Multiple Myeloma Type and Applications
Table Collectis CAR T-Cell Therapy for Multiple Myeloma Revenue, Gross Margin and Market Share (2016-2017)
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) by Players (2013-2018)
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue Share by Players (2013-2018)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Share by Players in 2016
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Share by Players in 2017
Figure Global Top 5 Players CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share in 2017
Figure Global Top 10 Players CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share in 2017
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) by Regions (2013-2018)
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Regions (2013-2018)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Regions (2013-2018)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Regions in 2017
Figure North America CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Europe CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure South America CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Table North America CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries (2013-2018)
Table North America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries (2013-2018)
Figure North America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries (2013-2018)
Figure North America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries in 2017
Figure USA CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Canada CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Mexico CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Table Europe CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) by Countries (2013-2018)
Figure Europe CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries (2013-2018)
Figure Europe CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries in 2017
Figure Germany CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure UK CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure France CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Russia CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Italy CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Table Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries in 2017
Figure China CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Japan CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Korea CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure India CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Table South America CAR T-Cell Therapy for Multiple Myeloma Revenue by Countries (2013-2018)
Table South America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries (2013-2018)
Figure South America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries (2013-2018)
Figure South America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries in 2017
Figure Brazil CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Argentina CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Colombia CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Table Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Countries in 2017
Figure Saudi Arabia CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure UAE CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Egypt CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure Nigeria CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Figure South Africa CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2013-2018)
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) by Type (2013-2018)
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue Share by Type (2013-2018)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Share by Type (2013-2018)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Share by Type in 2017
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue Forecast by Type (2018-2023)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share Forecast by Type (2018-2023)
Figure Global Monotherapy Revenue Growth Rate (2013-2018)
Figure Global Combination Therapy Revenue Growth Rate (2013-2018)
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue by Application (2013-2018)
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue Share by Application (2013-2018)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Share by Application (2013-2018)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Share by Application in 2017
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue Forecast by Application (2018-2023)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share Forecast by Application (2018-2023)
Figure Global Multiple Myeloma Revenue Growth Rate (2013-2018)
Figure Global Refractory or Relapsed Multiple Myeloma Revenue Growth Rate (2013-2018)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share Forecast by Regions (2018-2023)
Figure North America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
Figure Europe CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
Figure Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
Figure South America CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
Figure Middle East and Africa CAR T-Cell Therapy for Multiple Myeloma Revenue Market Forecast (2018-2023)
【レポートのキーワード】
多発性骨髄腫CAR T細胞療法、単剤療法、コンビネーションセラピー、多発性骨髄腫、難治性または再発多発性骨髄腫